Delivery Order SPE2DX22D0010-SPE2D826FCW79
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,882.22 to AmerisourceBergen Drug Corp on January 20, 2026, for Amphetamine Mix (AD) Extended Release Capsules 10mg, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,584.17 to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 20 mg, with a completion date of December 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg, with a ceiling value of $1,510.71 and a completion date of January 6, 2026. This delivery order represents a firm fixed price contract with no set-aside designation, competitively awarded under an existing Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,727.34 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) Extended-Release Capsules, 20mg, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order was placed at the contractor's primary location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $6,322.42 to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 10mg. The award, issued on December 15, 2025, with completion targeted for December 16, 2025, utilizes a firm fixed-price contract structure with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to the vendor's location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a contract ceiling value of $2,071.44 and a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,866.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25mg. The contract was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This was a competitive award with no set-aside designation. This delivery order represents a child contract under...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCW79Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,700.25 to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended-Release Capsules 25mg. This firm fixed-price, non-set-aside contract was awarded on February 2, 2026, with an ultimate completion date of February 3, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's federal contracting demonstrates consistent capability to meet government procurement requirements through open competition and efficiently fulfill essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/1/26 |